Skip to main content

Advertisement

SpringerLink
Log in

Islet cell autoantibodies in patients younger than 20 years of age with recently diagnosed diabetes in Northwest of Iran

  • Original Article
  • Published:
International Journal of Diabetes in Developing Countries Aims and scope Submit manuscript

Abstract

The presence or absence of islet cell autoantibodies is one of the most direct ways to distinguish between type 1 and 2 diabetic patients. The objective of the present study was to assess the prevalence of β-cell autoantibodies such as glutamic acid decarboxylase-65 antibodies (GADAs) and islet cell antibodies (ICA) among patients younger than 20 years of age with recently diagnosed diabetes in northwest of Iran. From 2006 to 2008, 163 patients were enrolled in this study. They were clinically classified into two groups: 136 with type 1 diabetes (T1D) and 27 with type 2 diabetes (T2D). Serum levels of GADAs, ICA and C-peptide were determined with enzyme linked immunosorbent assay (ELISA) kits. Fasting blood glucose and HbA1c levels were also determined. Chi-square test, independent t test and one-way analysis of variance were used for data analysis. The prevalence of GADAs in T1D patients was 33.1%, slightly lower than that of ICA 35.3%. Forty-eight patients (35.3%) with T1D were positive for ICA compared to only one (3.7%) in T2D patients. The overall occurrence of any autoantibody in T1D patients (60.3%) was significantly higher than that of T2D patients (18.5%) (P < 0.001). There was a statistically different association with family history of diabetes among the autoantibody positive versus autoantibody negative patients with T1D (P < 0.01). Our results confirmed the presence of GADAs and ICA in T1D patients in Iran, though roughly at a lower prevalence than that reported for Caucasian T1D patients, but very similar to other non-Caucasian ethnic populations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Atkinson MA, Eisenbarth GS. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet. 2001;358:221–9.

    Article  PubMed  CAS  Google Scholar 

  2. Kobayashi T, Tamemoto K, Nakanishi K. Immunogenetic and clinical characterization of slowly progressive IDDM. Diab Care. 1993;16:780–8.

    Article  CAS  Google Scholar 

  3. Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, et al. Identification of the 64 K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature. 1990;347:151–6.

    Article  PubMed  CAS  Google Scholar 

  4. Winter WE, Harris N, Schatz D. Type 1 diabetes islet autoantibody markers. Diab Technol Ther. 2002;4:817–39.

    Article  CAS  Google Scholar 

  5. American Diabetes Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diab Care. 2003;26 Suppl 1:S5–20.

    Google Scholar 

  6. Bingley PJ, Bonifacio E, Williams AJ, Genovese S, Bottazzo GF, Gale EA. Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes. 1997;46:1701–10.

    Article  PubMed  CAS  Google Scholar 

  7. Gorus FK, Goubert P, Semakula C, Vandewalle CL, De Schepper J, Scheen A, et al. IA-2- autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. The Belgian diabetes registry. Diabetologia. 1997;40:95–9.

    Article  PubMed  CAS  Google Scholar 

  8. Hagopian WA, Sanjeevi CB, Kockum I, Landin-Olsson M, Karlsen AE, Sundkvist G, et al. Glutamate decarboxylase-, insulin- and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J Clin Invest. 1995;95:1501–11.

    Article  Google Scholar 

  9. Turner R, Stratton I, Horton V, Manley S, Zimmet P, Mackay IR, et al. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK prospective diabetes study group. Lancet. 1997;350:1288–93.

    Article  PubMed  CAS  Google Scholar 

  10. Van Deutekom AW, Heine RJ, Simsek S. The islet autoantibody titres: their clinical relevance in latent autoimmune diabetes in adults (LADA) and the classification of diabetes mellitus. Diabet Med. 2008;25:117–25.

    Article  PubMed  Google Scholar 

  11. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539–53.

    Article  PubMed  CAS  Google Scholar 

  12. Unnikrishnan AG, Bhatia E, Bhatia V, Bhadada SK, Sahay RK, Kannan A, et al. Type 1 diabetes versus type 2 diabetes with onset in persons younger than 20 years of age. Ann NY Acad Sci. 2008;1150:239–44.

    Article  PubMed  CAS  Google Scholar 

  13. Damanhouri LH, Dromey JA, Christie MR, Nasrat HA, Ardawi MS, Robins RA, et al. Autoantibodies to GAD and IA-2 in Saudi Arabian diabetic patients. Diabet Med. 2005;22:448–52.

    Article  PubMed  CAS  Google Scholar 

  14. Wan Nazaimoon WM, Faridah I, Singaraveloo M, Ismail IS, Wan Mohamad WB, Letchuman R, et al. Prevalence of glutamic acid decarboxylase antibodies amongst young Malaysian diabetics. ; 1999;43:59–66.

    PubMed  CAS  Google Scholar 

  15. Lutale JJK, Thordarson H, Holm PJ, Eide GE, Vetvik K. Islet cell autoantibodies in African patients with type 1 and type 2 diabetes in Dar es Salaam Tanzania: a cross sectional study. J Autoimmune Dis. 2007;4:4–10.

    Article  PubMed  CAS  Google Scholar 

  16. Taplin CE, Barker JM. Autoantibodies in type 1 diabetes. Autoimmunity. 2008;41:11–8.

    Article  PubMed  CAS  Google Scholar 

  17. Imagawa A, Itoh N, Hanafusa T, Katsura H, Yamaguchi A, Takeda A, et al. High prevalence of antibodies to glutamic acid decarboxylase in comparison to islet cell antibodies in patients with long-standing insulin-dependent diabetes mellitus. Res Commun Mol Pathol Pharmacol. 1996;92:43–52.

    PubMed  CAS  Google Scholar 

  18. Kupila A, Muona P, Simell T, Arvilommi P, Savolainen H, Hamalainen AM, et al. Feasibility of genetic and immunological prediction of type I diabetes in a population-based birth cohort. Diabetologia. 2001;44:290–7.

    Article  PubMed  CAS  Google Scholar 

  19. Niskanen LK, Tuomi T, Karjalainen J, Groop LC, Uusitupa MI. GAD antibodies in NIDDM. Ten-year follow-up from the diagnosis. Diab Care. 1995;18:1557–65.

    Article  CAS  Google Scholar 

  20. Tung YC, Chen MH, Lee CT, Tsai WY. β-cell autoantibodies and their function in Taiwanese children with type 1 diabetes mellitus. J Formos Med Assoc. 2009;108:856–61.

    Article  PubMed  CAS  Google Scholar 

  21. Notsu K, Oka N, Note S, Nabeya N, Kuno S, Sakurami T. Islet cell antibodies in the Japanese population and subjects with type 1 (insulin-dependent) diabetes. Diabetologia. 1985;28:660–2.

    Article  PubMed  CAS  Google Scholar 

  22. Park Y, EIisenbarth GS. Genetic susceptibility factors of type 1 diabetes in Asians and their functional evaluation. Diab Metab Res Rev. 2001;17:2–11.

    Article  CAS  Google Scholar 

  23. Park Y, Lee H, Takino H, Abiru N, Kawasaki E, Eisenbarth GS. Evaluation of the efficacy of multiple autoantibody screening in Korean patients with IDDM. Acta Diabetol. 2001;38:51–66.

    Article  PubMed  CAS  Google Scholar 

  24. Omar MA, Bottazzo G, Asmal AC. Islet cell antibodies and other autoantibodies in South African blacks and Indians with insulin dependent diabetes mellitus (IDDM). Horm Metab Res. 1986;18:126–8.

    Article  PubMed  CAS  Google Scholar 

  25. Peters WH, Lester FT, Kohnert KD, Hildmann W. The frequency of islet cell surface antibodies in newly diagnosed diabetics from Ethiopia. Exp Clin Endocrinol. 1986;87:326–32.

    Article  PubMed  CAS  Google Scholar 

  26. Panz VR, Kalk WJ, Zouvanis M, Joffe BI. Distribution of autoantibodies to glutamic acid decarboxylase across the spectrum of diabetes mellitus seen in South Africa. Diabet Med. 2000;17:524–7.

    Article  PubMed  CAS  Google Scholar 

  27. Thunander M, Petersson C, Jonzon K, Fornander J, Ossiansson B, Torn C, et al. Incidence of type 1 and type 2 diabetes in adults and children in Kronoberg, Sweden. Diab Res Clin Pract. 2008;82:247–55.

    Article  CAS  Google Scholar 

  28. Rapaport R, Silverstein JH, Garzarella L, Rosenbloom AL. Type 1 and type 2 diabetes mellitus in childhood in the United States: practice patterns by pediatric endocrinologists. J Pediatr Endocrinol Metab. 2004;17:871–7.

    Article  PubMed  Google Scholar 

  29. Pozzilli P, Guglielmi C, Pronina E, Petraikina E. Double or hybrid diabetes associated with an increase in type 1 and type 2 diabetes in children and youths. Pediatr Diab. 2007;9:88–95.

    Article  Google Scholar 

  30. Wei Z, Wang K, Qu HQ, Zhang H, Bradfield J, Kim C, et al. From disease association to risk assessment: an optimistic view from genome-wide association studies on type 1 diabetes. PLoS Genet. 2009;5:1–11.

    Google Scholar 

  31. Aly TA, Ide A, Jahromi MM, Barker JM, Fernando MS, Babu SR, et al. Extreme genetic risk for type 1A diabetes. PNAS. 2006;103:14074–9.

    Article  PubMed  CAS  Google Scholar 

  32. Permutt MA, Wasson J, Cox N. Genetic epidemiology of diabetes. J Clin Invest. 2005;115:1431–9.

    Article  PubMed  CAS  Google Scholar 

  33. Gao P, Jiao Y, Xiong Q, Wang CY, Gerling I, Gu W. Genetic and molecular basis of QTL of diabetes in mouse: genes and polymorphisms. Curr Genomics. 2008;9:324–7.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgement

We would like to thank Mr. Parvin for his assistance with sample collection and organising laboratory tests.

Source of Support

This work is supported by a grant from the Research Deputy, Tabriz University of Medical Sciences, Tabriz, Iran

Conflicting Interest

None declared

Author information

Authors and Affiliations

  1. Immunology Department, Faculty of Medicine, Tabriz University of Medical Sciences, Golgasht Ave, Tabriz, Iran

    Leili Yazdchi Marandi & Mehrangiz Rajaii

  2. Endocrinology Department, Emam Reza Hospital, Tabriz University of Medical Sciences, Tabriz, Iran

    Akbar Aliasgarzadeh

  3. PHS Department, Karolinska Institute, Stokholm, Sweden

    Homayoun Sadeghi-Bazargani

  4. Research Development Center, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran

    Homayoun Sadeghi-Bazargani

Authors
  1. Leili Yazdchi Marandi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mehrangiz Rajaii
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Akbar Aliasgarzadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Homayoun Sadeghi-Bazargani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Leili Yazdchi Marandi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marandi, L.Y., Rajaii, M., Aliasgarzadeh, A. et al. Islet cell autoantibodies in patients younger than 20 years of age with recently diagnosed diabetes in Northwest of Iran. Int J Diabetes Dev Ctries 31, 70–75 (2011). https://doi.org/10.1007/s13410-011-0015-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13410-011-0015-5

Keywords

Search

Navigation